FDA对未经批准的药物采取行动。

FDA consumer Pub Date : 2007-01-01

Michelle Meadows

{"title":"FDA对未经批准的药物采取行动。","authors":"Michelle Meadows","doi":"","DOIUrl":null,"url":null,"abstract":"Most prescription drugs marketed in the United States have been reviewed and approved by the Food and Drug Administration as required by law. Thousands of unapproved prescription drugs, however, are still being prescribed and sold. The FDA, as part of its drug safety efforts, is bolstering its efforts against unapproved drugs in the United States.","PeriodicalId":76907,"journal":{"name":"FDA consumer","volume":"41 1","pages":"34-5"},"PeriodicalIF":0.0000,"publicationDate":"2007-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The FDA takes action against unapproved drugs.\",\"authors\":\"Michelle Meadows\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Most prescription drugs marketed in the United States have been reviewed and approved by the Food and Drug Administration as required by law. Thousands of unapproved prescription drugs, however, are still being prescribed and sold. The FDA, as part of its drug safety efforts, is bolstering its efforts against unapproved drugs in the United States.\",\"PeriodicalId\":76907,\"journal\":{\"name\":\"FDA consumer\",\"volume\":\"41 1\",\"pages\":\"34-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"FDA consumer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"FDA consumer","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

大多数在美国销售的处方药都经过了食品和药物管理局的审查和批准，这是法律要求的。然而，数千种未经批准的处方药仍在开处方和销售。作为其药品安全工作的一部分，FDA正在加强对美国未经批准的药物的打击力度。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

The FDA takes action against unapproved drugs.

Most prescription drugs marketed in the United States have been reviewed and approved by the Food and Drug Administration as required by law. Thousands of unapproved prescription drugs, however, are still being prescribed and sold. The FDA, as part of its drug safety efforts, is bolstering its efforts against unapproved drugs in the United States.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

FDA consumer

自引率

0.00%

发文量

期刊最新文献

Prostate cancer. Menopausal Hormone Therapy Genetics and drugs. New health claims proposed for calcium and osteoporosis. Rituxan warning.